.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Chinese Patent Office
Merck
McKesson
AstraZeneca
Deloitte
Fuji
Colorcon
Cantor Fitzgerald
Chubb

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for Patent: ➤ Subscribe

« Back to Dashboard

Details for Patent: ➤ Subscribe

Title: 5,6,7,8-Tetrahydro-1,6,7-naphthalenetriols
Abstract:5,6,7,8-Tetrahydro-1,6,7-naphthalenetriols having the formula ##STR1## wherein R.sup.8, R.sup.9 and R.sup.10 are the same or different and are hydrogen, lower alkyl, monocyclic aryl-lower alkyl, lower alkoxy, carboxy, or monocyclic cycloalkyl, are intermediates useful in the preparation of compounds used to treat coronary diseases.
Inventor(s): Hauck; Frederic P. (Somerville, NJ), Cimarusti; Christopher M. (Hamilton, NJ), Narayanan; Venkatachala L. (Hightstown, NJ)
Assignee: E. R. Squibb & Sons, Inc. (Princeton, NJ)
Filing Date:Oct 09, 1975
Application Number:05/620,980
Claims:1. Compounds of the structure ##STR82## wherein R.sup.8, R.sup.9, and R.sup.10 are the same or different and are hydrogen, lower alkyl, lower alkoxy, or cycloalkyl.

2. The compound in accordance with claim 1 wherein R.sup.8, R.sup.9, and R.sup.10 are hydrogen.

3. A compound in accordance with claim 1 wherein the adjacent hydroxy groups are in the trans configuration.

4. A compound in accordance with claim 1 wherein the two adjacent hydroxy groups are in the cis configurations.

5. A compound in accordance with claim 3 wherein R.sup.8, R.sup.9 and R.sup.10 are hydrogen.

6. A compound in accordance with claim 4 wherein R.sup.8, R.sup.9 and R.sup.10 are hydrogen.
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Federal Trade Commission
McKesson
Queensland Health
AstraZeneca
Farmers Insurance
Accenture
Healthtrust
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot